<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>640</ReferenceId>
        <DateLastUpdated>2013-06-21-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15039099</PubmedId>
            <Abstract>The capsule of Bacillus anthracis, a polymer of gamma-D-glutamic acid, functions as a virulence determinant and is a poor immunogen. In this study we show that antibodies reactive with the B. anthracis capsule can be elicited in mice by immunization with a conjugate consisting of a synthetic gamma-D-glutamic acid nonamer peptide (gamma-D-glu9) covalently coupled to keyhole limpet hemocyanin. The serum response to gamma-D-glu9 was comprised primarily of IgG antibodies that recognized an epitope requiring a minimum of four gamma-linked D-glutamic acid residues. Antibodies to (gamma-D-glu9) bound to the surface of encapsulated B. anthracis cells and mediated opsonophagoctosis. These findings suggest that anti-capsular antibodies could mediate the clearance of vegetative B. anthracis cells in vivo. Thus, inclusion of an immunogenic capsular component as well as protective antigen in new anthrax vaccines would generate immune responses targeting both the bacteremic and toxigenic aspects of anthrax infection and thus may increase protective efficacy.</Abstract>
            <ArticleYear>2004</ArticleYear>
            <ArticlePages>231-7</ArticlePages>
            <ArticleTitle>Induction of opsonic antibodies to the gamma-D-glutamic acid capsule of Bacillus anthracis by immunization with a synthetic peptide-carrier protein conjugate.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Taia T</ForeName>
                </Author>
                <Author>
                    <LastName>Fellows</LastName>
                    <ForeName>Patricia F</ForeName>
                </Author>
                <Author>
                    <LastName>Leighton</LastName>
                    <ForeName>Terrance J</ForeName>
                </Author>
                <Author>
                    <LastName>Lucas</LastName>
                    <ForeName>Alexander H</ForeName>
                </Author>
            </Authors>
            <Affiliations>Children's Hospital Oakland Research Institute, 5700 Martin Luther King Jr Way, Oakland, CA 94609, USA.</Affiliations>
            <ArticleChemicalList>Anthrax Vaccines;Antibodies, Bacterial;Antigens, Bacterial;Carrier Proteins;Epitopes;Immunoglobulin A;Immunoglobulin G;Immunoglobulin M;Opsonin Proteins;Vaccines, Conjugate;keyhole-limpet hemocyanin;Polyglutamic Acid;Hemocyanin</ArticleChemicalList>
            <ArticleMeshHeadingsList>Animals; Anthrax Vaccines(immunology); Antibodies, Bacterial(blood); Antigens, Bacterial(chemistry; immunology); Bacillus anthracis(immunology); Bacterial Capsules(chemistry; immunology); Carrier Proteins(chemistry; immunology); Epitopes(chemistry; immunology); Hemocyanin(chemistry; immunology); Immunoglobulin A(blood); Immunoglobulin G(blood); Immunoglobulin M(blood); Mice; Mice, Inbred BALB C; Opsonin Proteins(immunology); Phagocytosis(immunology); Polyglutamic Acid(chemistry; immunology); Vaccination; Vaccines, Conjugate(immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>40</Volume>
                <Issue>3</Issue>
                <Title>FEMS immunology and medical microbiology</Title>
                <Issn>0928-8244</Issn>
                <MedlineTa>FEMS Immunol Med Microbiol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>(γ-D-glu)&lt;sub&gt;9&lt;/sub&gt;</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EEEEEEEEE</LinearSequence>
                        <ModifiedResidues>1, 2, 3, 4, 5, 6, 7, 8, 9</ModifiedResidues>
                        <Modifications>D-aminoacid</Modifications>
                        <SourceMolecule>
                            <IedbAccession>SRC280246</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>1392</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Page 232</LocationOfData>
                <EpitopeId>125870</EpitopeId>
                <ReferenceStartingPosition>2</ReferenceStartingPosition>
                <ReferenceEndingPosition>10</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>This epitope is a nonamer consisting of D-glutamic acid residues linked at the γ-COOH groups.  It is derived from the capsule of Bacillus anthracis, which is a polymer of γ-D-glutamic acid.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 1</LocationOfData>
                        <BCellId>7417</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-10 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>DTREE_00000014</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EEEEEEEEE</LinearSequence>
                                            <ModifiedResidues>1, 2, 3, 4, 5, 6, 7, 8, 9</ModifiedResidues>
                                            <Modifications>D-aminoacid</Modifications>
                                            <SourceMolecule>
                                                <IedbAccession>SRC280246</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>1392</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>(γ-D-glu)&lt;sub&gt;9&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Four weeks after the first injection, mice receivedo a secnd subcutaneous injection of the antigen emulsified in IFA.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>5</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>5</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Antibody titers were significantly higher after the second immunization. Isotype analysis demonstrated that the antibodies were predominantly of the IgG1 subclass. However, lower responses to IgG2a, IgG2b, IgG3, IgM, and IgA were also shown.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>anti-(γ-D-glu)&lt;sub&gt;9&lt;/sub&gt;</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>(γ-D-glu)&lt;sub&gt;9&lt;/sub&gt;</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EEEEEEEEE</LinearSequence>
                                        <ModifiedResidues>1, 2, 3, 4, 5, 6, 7, 8, 9</ModifiedResidues>
                                        <Modifications>D-aminoacid</Modifications>
                                        <SourceMolecule>
                                            <IedbAccession>SRC280246</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>1392</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <BCellId>7423</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-10 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>DTREE_00000014</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EEEEEEEEE</LinearSequence>
                                            <ModifiedResidues>1, 2, 3, 4, 5, 6, 7, 8, 9</ModifiedResidues>
                                            <Modifications>D-aminoacid</Modifications>
                                            <SourceMolecule>
                                                <IedbAccession>SRC280246</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>1392</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>(γ-D-glu)&lt;sub&gt;9&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Four weeks after the first injection, mice received a second subcutaneous injection of the antigen emulsified in IFA.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>38</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Antibodies bound to the encapsulated Ames strain of Bacillus anthracis, but not to non-encapsulated Sterne strain.  Specificity of antibodies was evaluated using a serum pool prepared by combining serum samples from mice that had received two injections.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>anti-(γ-D-glu)&lt;sub&gt;9&lt;/sub&gt;</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Bacillus anthracis</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>1392</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 4A and 4B</LocationOfData>
                        <BCellId>7428</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-10 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>DTREE_00000014</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EEEEEEEEE</LinearSequence>
                                            <ModifiedResidues>1, 2, 3, 4, 5, 6, 7, 8, 9</ModifiedResidues>
                                            <Modifications>D-aminoacid</Modifications>
                                            <SourceMolecule>
                                                <IedbAccession>SRC280246</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>1392</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>(γ-D-glu)&lt;sub&gt;9&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Four weeks after the first injection, mice received a second subcutaneous injection of the antigen emulsified in IFA.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>303</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The assay was a flow cytometric opsonophagocytosis assay. RAW 264.7 cells that had taken-up bacilli gave a fluorescent peak two orders of magnitude brighter than background fluorescence. Levels of phagocytosis were expressed as percentage of fluorescence-positive gated RAW 264.7 cells.  The level of opsonophagocytosis was reduced by inhibition with both the epitope, and with B. licheniformis poly-glutamic acid.  Specificity of antibodies was evaluated using a serum pool prepared by combining serum samples from mice that had received two injections.  Fluorescein-labeled heat-killed encapsulated B.anthracis bacilli (Ames strain) were incubated with various dilutions of an antibody followed by addition of RAW 264.7 cells.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>anti-(γ-D-glu)&lt;sub&gt;9&lt;/sub&gt;</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Bacillus anthracis</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Organism</EpitopeRelation>
                                <Object>
                                    <Organism>
                                        <SubType>Organism</SubType>
                                        <SourceOrganismId>1392</SourceOrganismId>
                                    </Organism>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <BCellId>7422</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>8-10 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <DiseaseState>DTREE_00000014</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EEEEEEEEE</LinearSequence>
                                            <ModifiedResidues>1, 2, 3, 4, 5, 6, 7, 8, 9</ModifiedResidues>
                                            <Modifications>D-aminoacid</Modifications>
                                            <SourceMolecule>
                                                <IedbAccession>SRC280246</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>1392</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>(γ-D-glu)&lt;sub&gt;9&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <ComplexedMolecule>
                                        <ComplexType>Protein conjugate</ComplexType>
                                        <PeptideModifications/>
                                        <SourceMolecule>
                                            <IedbAccession>SRC40074</IedbAccession>
                                        </SourceMolecule>
                                        <MoleculeSourceOrganismId>55429</MoleculeSourceOrganismId>
                                    </ComplexedMolecule>
                                </ImmunogenContainingObject>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Adjuvant>Freund's incomplete (IFA)</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>Four weeks after the first injection, mice received a second subcutaneous injection of the antigen emulsified in IFA.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>311</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The homologous nonamer peptide effectively inhibited serum antibody binding to the gamma-linked, biotinylated nonamer immobilized in the solid phase. This was also true of peptides consisting of six and four residues. However, inhibition was significantly lessened with peptides of three residues or shorter. Inhibition was also shown with the poly-glutamic acid of B. licheniformis.  Specificity of antibodies was evaluated using a serum pool prepared by combining serum samples from mice that had received two injections.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Polyclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>anti-(γ-D-glu)&lt;sub&gt;9&lt;/sub&gt;</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>(γ-D-glu)&lt;sub&gt;9&lt;/sub&gt;</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EEEEEEEEE</LinearSequence>
                                        <ModifiedResidues>1, 2, 3, 4, 5, 6, 7, 8, 9</ModifiedResidues>
                                        <Modifications>D-aminoacid</Modifications>
                                        <SourceMolecule>
                                            <IedbAccession>SRC280246</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>1392</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

